Literature DB >> 19661808

Impact of false-positive newborn metabolic screening results on early health care utilization.

Ellen A Lipstein1, James M Perrin, Susan E Waisbren, Lisa A Prosser.   

Abstract

PURPOSE: To analyze the association between false-positive newborn screening results and health care utilization.
METHODS: We surveyed parents regarding their children's health care utilization. Parents of children who received false-positive newborn screening results were primarily enrolled by a screening laboratory in Pennsylvania. Parents of children with normal results were recruited through the Massachusetts birth registry. We used bivariate tests and multivariate regression to assess the association between newborn screening results and primary care utilization, emergency room use, and hospitalization by the age of 6 months.
RESULTS: Our sample included 200 children with false-positive results and 137 with normal results. Variation in recruitment strategies led to sample children with false-positive results being more likely to be non-white, have unmarried parents, and be of lower socioeconomic status. After adjusting for significant covariates, such as age, race, and socioeconomic status, there were no significant associations between newborn screening results and child health care utilization.
CONCLUSIONS: Despite the reported negative psychosocial effects of false-positive results, our study found no impact on early health care utilization. These results may assist in economic analyses of newborn screening as they suggest that medical costs associated with false-positive results are limited to the cost of diagnostic testing and follow-up.

Entities:  

Mesh:

Year:  2009        PMID: 19661808      PMCID: PMC2773165          DOI: 10.1097/GIM.0b013e3181b3a61e

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  30 in total

Review 1.  Newborn screening for cystic fibrosis: ensuring more good than harm.

Authors:  Michael H Farrell; Philip M Farrell
Journal:  J Pediatr       Date:  2003-12       Impact factor: 4.406

Review 2.  Neonatal screening by DNA microarray: spots and chips.

Authors:  Nancy S Green; Kenneth A Pass
Journal:  Nat Rev Genet       Date:  2005-02       Impact factor: 53.242

3.  Content of communication by pediatric residents after newborn genetic screening.

Authors:  Michael H Farrell; Alison La Pean; Lynnea Ladouceur
Journal:  Pediatrics       Date:  2005-12       Impact factor: 7.124

4.  State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results.

Authors:  Beth A Tarini; Dimitri A Christakis; H Gilbert Welch
Journal:  Pediatrics       Date:  2006-08       Impact factor: 7.124

5.  Comprehensive cost-utility analysis of newborn screening strategies.

Authors:  Aaron E Carroll; Stephen M Downs
Journal:  Pediatrics       Date:  2006-05       Impact factor: 7.124

6.  Iatrogenesis: the PKU anxiety syndrome.

Authors:  M B Rothenberg; E M Sills
Journal:  J Am Acad Child Psychiatry       Date:  1968-10

7.  Children's health care use: a prospective investigation of factors related to care-seeking.

Authors:  D M Janicke; J W Finney; A W Riley
Journal:  Med Care       Date:  2001-09       Impact factor: 2.983

8.  Maternal rating of child health at school age: does the vulnerable child syndrome persist?

Authors:  M C McCormick; J Brooks-Gunn; K Workman-Daniels; G J Peckham
Journal:  Pediatrics       Date:  1993-09       Impact factor: 7.124

9.  Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications.

Authors:  Andreas Schulze; Martin Lindner; Dirk Kohlmüller; Katharina Olgemöller; Ertan Mayatepek; Georg F Hoffmann
Journal:  Pediatrics       Date:  2003-06       Impact factor: 7.124

10.  Vulnerable children: parents' perspectives and the use of medical care.

Authors:  J C Levy
Journal:  Pediatrics       Date:  1980-05       Impact factor: 7.124

View more
  18 in total

1.  False-positive newborn screening result and future health care use in a state Medicaid cohort.

Authors:  Beth A Tarini; Sarah J Clark; Subra Pilli; Kevin J Dombkowski; Steven J Korzeniewski; Acham Gebremariam; Jon Eisenhandler; Violanda Grigorescu
Journal:  Pediatrics       Date:  2011-09-19       Impact factor: 7.124

2.  Expanded newborn screening: reducing harm, assessing benefit.

Authors:  Bridget Wilcken
Journal:  J Inherit Metab Dis       Date:  2010-05-04       Impact factor: 4.982

3.  Qualitative Research on Expanded Prenatal and Newborn Screening: Robust but Marginalized.

Authors:  Rachel Grob
Journal:  Hastings Cent Rep       Date:  2019-05       Impact factor: 2.683

4.  Application of a second-tier newborn screening assay for c5 isoforms.

Authors:  T Cloppenborg; N Janzen; Hj Wagner; U Steuerwald; M Peter; Am Das
Journal:  JIMD Rep       Date:  2013-11-06

Review 5.  Genetic screening.

Authors:  Wylie Burke; Beth Tarini; Nancy A Press; James P Evans
Journal:  Epidemiol Rev       Date:  2011-06-27       Impact factor: 6.222

6.  Impact of new screening technologies: should we screen and does phenotype influence this decision?

Authors:  James Robert Bonham
Journal:  J Inherit Metab Dis       Date:  2013-03-19       Impact factor: 4.982

Review 7.  Newborn screening and renal disease: where we have been; where we are now; where we are going.

Authors:  J Lawrence Merritt; David Askenazi; Si Houn Hahn
Journal:  Pediatr Nephrol       Date:  2011-09-27       Impact factor: 3.714

8.  Factors associated with parental perception of child vulnerability 12 months after abnormal newborn screening results.

Authors:  Audrey Tluczek; Anne Chevalier McKechnie; Roger L Brown
Journal:  Res Nurs Health       Date:  2011-08-24       Impact factor: 2.228

Review 9.  Ethical issues with newborn screening in the genomics era.

Authors:  Beth A Tarini; Aaron J Goldenberg
Journal:  Annu Rev Genomics Hum Genet       Date:  2012-05-01       Impact factor: 8.929

10.  Whole Genome Sequencing and Newborn Screening.

Authors:  Jeffrey R Botkin; Erin Rothwell
Journal:  Curr Genet Med Rep       Date:  2016-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.